Molecular alterations in <i>IDH</i>-mutant astrocytoma: A multi-institutional retrospective study
Age and CNS WHO grade remain essentials for risk stratification among <i>IDH</i>-mutant astrocytoma patients. Further studies are warranted to determine the prognostic implications of <i>BRCA2</i> mutations and TMB.
Authors
- Chirag B. Patel (ORCID: https://orcid.org/0000-0003-0787-0634)
- Hanim I. Ozkizilkaya
- Leomar Y. Ballester (ORCID: https://orcid.org/0000-0002-6854-6830)
- Keng Lam (ORCID: https://orcid.org/0000-0002-4480-2801)
- Antonio Dono (ORCID: https://orcid.org/0000-0002-8041-8399)
- Jason M. Johnson (ORCID: https://orcid.org/0000-0001-7724-5784)
- Suprateek Kundu (ORCID: https://orcid.org/0000-0002-1767-4875)
- Yoshua Esquenazi (ORCID: https://orcid.org/0000-0002-9757-1453)
- Yajie Liu (ORCID: https://orcid.org/0000-0002-4555-3472)
- Denái R. Milton
- Vinodh A Kumar
Institutions
- University of Southern California (US)
- The University of Texas MD Anderson Cancer Center (US)
- Yale University (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/noajnl/vdaf088
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00